Chornenkyy Y, Yamamoto T, Hara H, Stowell S, Ghiran I, Robson S
Blood Rev. 2023; 61:101113.
PMID: 37474379
PMC: 10968389.
DOI: 10.1016/j.blre.2023.101113.
Zittersteijn H, Harteveld C, Klaver-Flores S, Lankester A, Hoeben R, Staal F
Front Genome Ed. 2021; 2:617780.
PMID: 34713239
PMC: 8525365.
DOI: 10.3389/fgeed.2020.617780.
Barminko J, Vacaru A, Baron M
Methods Mol Biol. 2021; 2224:153-182.
PMID: 33606214
DOI: 10.1007/978-1-0716-1008-4_12.
Tang K, Yu C, Jiang L, Gong M, Liu W, Wang Y
Toxicol Res (Camb). 2018; 5(5):1284-1297.
PMID: 30090432
PMC: 6062335.
DOI: 10.1039/c6tx00143b.
Philipsen S, Hardison R
Blood Cells Mol Dis. 2017; 70:2-12.
PMID: 28811072
PMC: 5807248.
DOI: 10.1016/j.bcmd.2017.08.001.
A long-range flexible billboard model of gene activation.
Vockley C, McDowell I, DIppolito A, Reddy T
Transcription. 2017; 8(4):261-267.
PMID: 28598247
PMC: 5574526.
DOI: 10.1080/21541264.2017.1317694.
Current and future alternative therapies for beta-thalassemia major.
de Dreuzy E, Bhukhai K, Leboulch P, Payen E
Biomed J. 2016; 39(1):24-38.
PMID: 27105596
PMC: 6138429.
DOI: 10.1016/j.bj.2015.10.001.
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
Negre O, Eggimann A, Beuzard Y, Ribeil J, Bourget P, Borwornpinyo S
Hum Gene Ther. 2016; 27(2):148-65.
PMID: 26886832
PMC: 4779296.
DOI: 10.1089/hum.2016.007.
Skeletal defects in Osterix-Cre transgenic mice.
Huang W, Olsen B
Transgenic Res. 2014; 24(1):167-72.
PMID: 25139670
PMC: 4276445.
DOI: 10.1007/s11248-014-9828-6.
Generation of transgenic mouse fluorescent reporter lines for studying hematopoietic development.
Vacaru A, Vitale J, Nieves J, Baron M
Methods Mol Biol. 2014; 1194:289-312.
PMID: 25064110
PMC: 4418647.
DOI: 10.1007/978-1-4939-1215-5_16.
Fetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathies.
Suzuki M, Yamamoto M, Engel J
Mol Cell Biol. 2014; 34(19):3560-9.
PMID: 25022757
PMC: 4187729.
DOI: 10.1128/MCB.00714-14.
Adapting in vitro embryonic stem cell differentiation to the study of locus control regions.
Lahiji A, Kucerova-Levisohn M, Holmes R, Zuniga-Pflucker J, Ortiz B
J Immunol Methods. 2014; 407:135-45.
PMID: 24681242
PMC: 4037339.
DOI: 10.1016/j.jim.2014.03.012.
Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.
Stowell S, Henry K, Smith N, Hudson K, Halverson G, Park J
Blood. 2013; 122(8):1494-504.
PMID: 23801629
PMC: 3750342.
DOI: 10.1182/blood-2013-03-488874.
Extensions of MADM (mosaic analysis with double markers) in mice.
Tasic B, Miyamichi K, Hippenmeyer S, Dani V, Zeng H, Joo W
PLoS One. 2012; 7(3):e33332.
PMID: 22479386
PMC: 3314016.
DOI: 10.1371/journal.pone.0033332.
Site-specific integrase-mediated transgenesis in mice via pronuclear injection.
Tasic B, Hippenmeyer S, Wang C, Gamboa M, Zong H, Chen-Tsai Y
Proc Natl Acad Sci U S A. 2011; 108(19):7902-7.
PMID: 21464299
PMC: 3093482.
DOI: 10.1073/pnas.1019507108.
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.
Wilber A, Nienhuis A, Persons D
Blood. 2011; 117(15):3945-53.
PMID: 21321359
PMC: 3087525.
DOI: 10.1182/blood-2010-11-316893.
Human globin knock-in mice complete fetal-to-adult hemoglobin switching in postnatal development.
McConnell S, Huo Y, Liu S, Ryan T
Mol Cell Biol. 2010; 31(4):876-83.
PMID: 21173165
PMC: 3028651.
DOI: 10.1128/MCB.00725-10.
Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers.
Li F, Cheng Q, Ling X, Stablewski A, Tang L, Foster B
Am J Pathol. 2010; 176(4):1629-38.
PMID: 20133811
PMC: 2843455.
DOI: 10.2353/ajpath.2010.090414.
Generating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes.
Van Keuren M, Gavrilina G, Filipiak W, Zeidler M, Saunders T
Transgenic Res. 2009; 18(5):769-85.
PMID: 19396621
PMC: 3016422.
DOI: 10.1007/s11248-009-9271-2.
Homogeneity and persistence of transgene expression by omitting antibiotic selection in cell line isolation.
Kaufman W, Kocman I, Agrawal V, Rahn H, Besser D, Gossen M
Nucleic Acids Res. 2008; 36(17):e111.
PMID: 18682524
PMC: 2553579.
DOI: 10.1093/nar/gkn508.